Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.18 million shares were traded. CRBU stock price reached its highest trading level at $1.86 during the session, while it also had its lowest trading level at $1.7301.
Ratios:
We take a closer look at CRBU’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.54 and its Current Ratio is at 5.54. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In the most recent recommendation for the company, Evercore ISI on June 03, 2024, Downgraded its rating to In-line and sets its target price to $3 from $13 previously.
On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.Evercore ISI initiated its Outperform rating on October 31, 2023, with a $13 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 14 ’25 when Haurwitz Rachel E. bought 20,000 shares for $1.02 per share. The transaction valued at 20,400 led to the insider holds 3,369,395 shares of the business.
MCCLUNG BARBARA G sold 3,564 shares of CRBU for $4,811 on Feb 21 ’25. The Chief Legal Officer now owns 443,502 shares after completing the transaction at $1.35 per share. On Feb 21 ’25, another insider, Khan Ruhi Ahmad, who serves as the Chief Business Officer of the company, sold 3,564 shares for $1.35 each. As a result, the insider received 4,811 and left with 66,936 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 163569072 and an Enterprise Value of 41774068. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.61 while its Price-to-Book (P/B) ratio in mrq is 1.15. Its current Enterprise Value per Revenue stands at 4.494 whereas that against EBITDA is -0.308.
Stock Price History:
The Beta on a monthly basis for CRBU is 2.65, which has changed by -0.13366336 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, CRBU has reached a high of $3.54, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -21.66%, while the 200-Day Moving Average is calculated to be 12.51%.
Shares Statistics:
According to the various share statistics, CRBU traded on average about 2.24M shares per day over the past 3-months and 1447270 shares per day over the past 10 days. A total of 93.47M shares are outstanding, with a floating share count of 82.74M. Insiders hold about 11.48% of the company’s shares, while institutions hold 36.85% stake in the company. Shares short for CRBU as of 1761868800 were 3546605 with a Short Ratio of 1.58, compared to 1759190400 on 4074512. Therefore, it implies a Short% of Shares Outstanding of 3546605 and a Short% of Float of 3.9899999999999998.
Earnings Estimates
The market rating for Caribou Biosciences Inc (CRBU) is a result of the insights provided by 7.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.3 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.5 and -$1.65 for the fiscal current year, implying an average EPS of -$1.59. EPS for the following year is -$1.36, with 8.0 analysts recommending between -$0.87 and -$1.81.
Revenue Estimates
For the next quarter, 8 analysts are estimating revenue of $2.65M. There is a high estimate of $2.8M for the next quarter, whereas the lowest estimate is $2.5M.
A total of 7 analysts have provided revenue estimates for CRBU’s current fiscal year. The highest revenue estimate was $10M, while the lowest revenue estimate was $7.2M, resulting in an average revenue estimate of $9.38M. In the same quarter a year ago, actual revenue was $9.99M
